Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>M Stanley: PA GOODDOCTOR 1Q Results Show Operations Progressing Toward Full-Yr Target; Rating Equalweight
Recommend 9 Positive 8 Negative 8 |
||||
|
||||
|
PA GOODDOCTOR (01833.HK)'s 1Q26 results reflected operations advancing toward its full-year target, Morgan Stanley said in a research report. 1Q26 revenue added 9.1% YoY to RMB1.16 billion; net profit swelled 138.4% YoY to RMB79.1 million; adjusted net profit grew 45.8% YoY to RMB84.4 million. The broker noted that the modest revenue growth likely reflects change of service offering models and accounting method, while profit growth better demonstrates the real economics. As of the end of 1Q26, the number of AI doctor users numbered 5.6 million, with about 95% AI assisted accuracy for complex disease plans from the MDT platform. The broker assigned PA GOODDOCTOR a TP of HKD16.8 and maintained an Equalweight rating. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
